Bank Of New York Mellon Corp 10x Genomics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

A detailed history of Bank Of New York Mellon Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 335,368 shares of TXG stock, worth $4.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

335,368

Previous 328,181 2.19%

Holding current value

$4.47 Million

Previous $6.38 Billion 18.63%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.71 - $23.49 $112,907 - $168,822	7,187 Added 2.19%	335,368 $7.57 Billion
Q2 2024 Jul 25, 2024	SELL	$19.45 - $37.37 $10.2 Million - $19.5 Million	-522,634 Reduced 61.43%	328,181 $6.38 Billion
Q1 2024 Apr 25, 2024	SELL	$36.08 - $54.3 $3.48 Million - $5.24 Million	-96,578 Reduced 10.19%	850,815 $31.9 Billion
Q4 2023 Jan 29, 2024	SELL	$34.32 - $57.55 $2.16 Million - $3.62 Million	-62,863 Reduced 6.22%	947,393 $53 Billion
Q3 2023 Oct 24, 2023	BUY	$40.86 - $62.98 $5.03 Million - $7.75 Million	122,981 Added 13.86%	1,010,256 $41.7 Billion
Q2 2023 Aug 03, 2023	BUY	$50.96 - $58.72 $4.54 Million - $5.23 Million	89,127 Added 11.17%	887,275 $49.5 Billion
Q1 2023 May 09, 2023	BUY	$35.33 - $55.79 $28.2 Million - $44.5 Million	798,148 New	798,148 $44.5 Billion
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $19.8 Million - $33.6 Million	812,699 New	812,699 $29.6 Million
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $529,784 - $978,279	-18,602 Reduced 2.24%	811,358 $23.1 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $152,973 - $341,177	-4,140 Reduced 0.5%	829,960 $37.6 Million
Q1 2022 May 11, 2022	BUY	$55.7 - $145.79 $4.86 Million - $12.7 Million	87,322 Added 11.69%	834,100 $63.5 Million
Q4 2021 Feb 11, 2022	SELL	$135.05 - $182.59 $962,501 - $1.3 Million	-7,127 Reduced 0.95%	746,778 $111 Million
Q3 2021 Nov 12, 2021	BUY	$145.58 - $192.14 $3.22 Million - $4.24 Million	22,085 Added 3.02%	753,905 $110 Million
Q2 2021 Aug 11, 2021	SELL	$134.22 - $202.37 $8.97 Million - $13.5 Million	-66,799 Reduced 8.36%	731,820 $143 Million
Q1 2021 May 13, 2021	BUY	$140.25 - $196.86 $6.88 Million - $9.66 Million	49,088 Added 6.55%	798,619 $145 Million
Q4 2020 Feb 09, 2021	BUY	$126.47 - $163.7 $12.9 Million - $16.7 Million	101,766 Added 15.71%	749,531 $106 Million
Q3 2020 Nov 12, 2020	BUY	$87.44 - $125.0 $5.33 Million - $7.62 Million	60,976 Added 10.39%	647,765 $80.8 Million
Q2 2020 Aug 12, 2020	BUY	$58.39 - $89.31 $7.18 Million - $11 Million	123,031 Added 26.53%	586,789 $52.4 Million
Q1 2020 May 06, 2020	BUY	$51.57 - $106.62 $14.8 Million - $30.5 Million	286,253 Added 161.26%	463,758 $28.9 Million
Q4 2019 Feb 14, 2020	BUY	$46.07 - $79.54 $7.9 Million - $13.6 Million	171,516 Added 2863.85%	177,505 $13.5 Million
Q3 2019 Nov 07, 2019	BUY	$49.99 - $62.0 $299,390 - $371,318	5,989 New	5,989 $301,000

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.27B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account

Bank Of New York Mellon Corp 10x Genomics, Inc. Transaction History